<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Global Business on FinanClub</title>
    <link>https://finan.club/tags/global-business/</link>
    <description>Recent content in Global Business on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 18 Aug 2023 10:57:10 +0000</lastBuildDate><atom:link href="https://finan.club/tags/global-business/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>VTRS</title>
      <link>https://finan.club/us/vtrs/</link>
      <pubDate>Fri, 18 Aug 2023 10:57:10 +0000</pubDate>
      
      <guid>https://finan.club/us/vtrs/</guid>
      <description>score:-14
Chances: Viatris, a generic drugmaker, serves patients and customers in over 165 countries with a diverse global business. Viatris&amp;rsquo; potential divestitures and new multiple sclerosis treatment could contribute to positive sentiment. Viatris is a stock of interest among the dividend investing community due to its stable line of business.</description>
    </item>
    
  </channel>
</rss>
